82
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease

, , , , , & show all
Pages 39-46 | Published online: 18 Dec 2013

References

  • ShererTBBetarbetRGreenamyreJTPathogenesis of Parkinson’s diseaseCurr Opin Investig Drugs20012657662
  • YangXWuNSongLLiuZIntrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s diseaseNeuropsychiatr Dis Treat201391213122023983471
  • EskowKLDupreKBBarnumCJDickinsonSOParkJYBishopCThe role of the dorsal raphe nucleus in the development, expression, and treatment of LID in hemiparkinsonian ratsSynapse20096361062019309758
  • JankovicJParkinson’s disease therapy: treatment of early and late diseaseChin Med J200111422723411780303
  • JaunarajsKLDupreKBSteinigerASerotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesiaNeuroreport2009201265126919633584
  • CartaMCarlssonTKirikDBjörklundADopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian ratsBrain20071301819183317452372
  • YangXChenYHongXLevodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned ratsDrug Des Devel Ther20126341347
  • PaquetteMAMartinezAAMachedaTAnti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs 5-HT1A receptorsEur J Neurosci2012363224323422861201
  • ElahiBPhielippNChenRN-methyl-D-aspartate antagonists in levodopa induced dyskinesia: a meta-analysisCan J Neurol Sci20123946547222728853
  • JohnstonTHvan der MeijABrotchieJMFoxSHEffect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson’s diseaseMov Disord2010251379139020310030
  • AnichtchikOVRinneJOKalimoHPanulaPAn altered histaminergic innervation of the substantia nigra in Parkinson’s diseaseExp Neurol2000163203010785440
  • RinneJOAnichtchikOVErikssonKSIncreased brain histamine levels in Parkinson’s disease but not in multiple system atrophyJ Neurochem20028195496012065607
  • ParsonsMEGanellinCRHistamine and its receptorsBr J Pharmacol2006147Suppl 1S127S13516402096
  • VizueteMLTraiffortEBouthenetMLDetailed mapping of the histamine H2 receptor and its gene transcripts in guinea pig brainNeuroscience1997803213439284338
  • PisaniABernardiGDingJSurmeierDJRe-emergence of striatal cholinergic interneurons in movement disordersTrends Neurosci20073054555317904652
  • PaxinosGWatsonCThe Rat Brain in Stereotaxic CoordinatesSan Diego, CA, USAAcademic Press2007
  • SchwartingRKHustonJPThe unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatmentsProg Neurobiol1996502753318971983
  • CartaMLindgrenHSLundbladMStancampianoRFaddaFCenciMARole of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned ratsJ Neurochem2006961718172716539687
  • RenTYangXWuNCaiYLiuZYuanWSustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned ratsNeurosci Lett201150211712221835223
  • OuattaraBHoyerDGrégoireLChanges of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesiasNeuroscience20101671160116720303391
  • MorissetteMDridiMCalonFPrevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptorsSynapse20066023925016739115
  • Elzinga-HuttengaJHeksterYBijlARotteveelJMovement disorders induced by gastrointestinal drugs: two paediatric casesNeuropediatrics20063710210616773510
  • KapurVBarberKRPeddireddyRRanitidine-induced acute dystoniaAm J Emerg Med19991725826010337885
  • ZhouFWXuJJZhaoYLeDouxMSZhouFMOpposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulataJ Neurophysiol2006961581159116738217
  • PrastHTranMHLambertiCHistaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptorsNaunyn Schmiedebergs Arch Pharmacol199936055255710598794
  • SittigNDavidowaHHistamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized ratsBehav Brain Res200112413714311640966
  • TongJFitzmauricePSAngLCFurukawaYGuttmanMKishSJBrain dopamine-stimulated adenylyl cyclase activity in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyAnn Neurol20045512512914705122
  • AubertIGuigoniCHåkanssonKIncreased D1 dopamine receptor signaling in levodopa-induced dyskinesiaAnn Neurol200557172615514976
  • CorvolJCMurielMPValjentEPersistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson diseaseJ Neurosci2004247007701415295036
  • PicconiBCentonzeDHåkanssonKLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesiaNat Neurosci2003650150612665799
  • GreengardPThe neurobiology of slow synaptic transmissionScience20012941024103011691979
  • Sgambato-FaureVBuggiaVGilbertFLévesqueDBenabidALBergerFCoordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic ratsJ Neuropathol Exp Neurol20056493694716254488
  • SvenningssonPFienbergAAAllenPBDopamine D(1) receptor-induced gene transcription is modulated by DARPP-32J Neurochem20007524825710854268
  • ZachariouVSgambato-FaureVSasakiTPhosphorylation of DARPP-32 at threonine-34 is required for cocaine actionNeuropsychopharmacology20063155556216123776
  • MaraisRWynneJTreismanRThe SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell1993733813938386592
  • SantiniEValjentEFisoneGParkinson’s disease: levodopa-induced dyskinesia and signal transductionFEBS J20082751392139918279379